Chemours Announces Board Changes and Executive Compensation Updates
Ticker: CC · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: CC
TL;DR
Chemours board shake-up: Vergnani out, Miller & Villers in. Exec comp details also filed.
AI Summary
On January 3, 2025, The Chemours Company filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the company announced the departure of director Mark P. Vergnani and the appointment of new directors, including David L. Miller and Christopher J. Villers. The filing also addresses compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive appointments, with no immediate financial distress or significant operational changes indicated.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Mark P. Vergnani (person) — Departing Director
- David L. Miller (person) — Appointed Director
- Christopher J. Villers (person) — Appointed Director
- January 3, 2025 (date) — Date of Report
FAQ
Who has been appointed to The Chemours Company's board of directors?
David L. Miller and Christopher J. Villers have been appointed to the board of directors.
Which director has departed from The Chemours Company's board?
Mark P. Vergnani has departed from the board of directors.
What is the date of this 8-K filing?
The date of the report is January 3, 2025.
What are the main topics covered in this 8-K filing?
The filing covers the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the principal executive office address for The Chemours Company?
The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.
Filing Stats: 647 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2025-01-07 06:35:57
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- cc-20250103.htm (8-K) — 55KB
- cc-ex99_1.htm (EX-99.1) — 22KB
- img15408389_0.jpg (GRAPHIC) — 37KB
- img173604626_0.jpg (GRAPHIC) — 35KB
- 0000950170-25-002553.txt ( ) — 330KB
- cc-20250103.xsd (EX-101.SCH) — 29KB
- cc-20250103_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release, dated as of January 7, 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Shane Hostetter Shane Hostetter Senior Vice President, Chief Financial Officer Date: January 7, 2025